Intravesical botulinum toxin type A in chronic interstitial cystitis: results of a pilot study.
To assess the efficacy of intravesical botulinum toxin type A (BTX-A) in interstitial cystitis (IC). Eleven patients with IC were injected with BTX-A. Primary outcome measures were: Bristol Female Lower Urinary Tract Symptom Score, Kings Health Questionnaire and 24-hour frequency-volume chart. They had urodynamics done before and six weeks after injection. Detrusor contractility was assessed using the modified PIP1 (projected isovolumetric detrusor pressure).